Research Areas
Health care; biopharmaceuticals; insurance; liability; medical malpractice; industrial organization
Current Projects
Pharmaceutical pricing in global markets, regulation and competition, alliances, R&D productivity, vaccine supply, Medicare payment for pharmaceuticals. Medical malpractice insurance cycles. Health care financing in the U.S. and internationally.
Education
PhD, University of Chicago, 1973; MA, University of Chicago, 1969; BA, University of Oxford, 1968
Recent Consulting
Pharmaceutical regulation (Pfizer, Merck, Aventis etc.), 1994-present; Insurance regulation, Alliance of American Insurers, 1977-93, Insurance Services Office, 1988-95; Medical malpractice, American Medical Association, American Hospital Association, The Rand Corporation, 1984-94; Health Insurance, Health Insurance Association of America, Government of New Zealand, 1990-94, World Bank, Asian Development Bank
Career and Recent Professional Awards; Teaching Awards
Institute of Medicine; Research Associate, National Bureau of Economic Research; National Academies, Policy & Global Affairs Oversight Board; National Institutes of Health, Fogarty International Center Advisory Board, 2004–2008; Robert C. Witt Research Award, American Risk and Insurance Association, 1995; Elizur Wright Award, American Risk and Insurance Association, 1988
Academic Positions Held
Wharton: 1985-present (Chairperson, Health Care Systems Department, 2004-2008; 1994-97; named Celia Z. Moh Professor, 1991). Previous appointment: Duke University. Visiting appointments: University of Chicago; Australian National University; Victoria University, New Zealand
Other Positions
Senior Research Fellow, Hoover Institution, 1980-84; Research Economist, The Rand Corporation, 1974-80
Professional Leadership 2005-2009
Associate Editor, Journal of Health Economics; Policy Board Member, Office of Health Economics, London; Associate Editor, International Journal of Health Care Finance;
Corporate and Public Sector Leadership 2005-2009
Board of Directors, Medarex Inc.; National Academy of Social Insurance; GAVI, Economic Expert Group on Advance Market Commitment for Pneumococcal Vaccine, 2007-8.
